Home » Armagen Receives U.S. Orphan Designation for AGT-182
Armagen Receives U.S. Orphan Designation for AGT-182
Armagen has received the FDA’s orphan drug designation for its drug AGT-182 to treat Hunter Syndrome, an X-linked genetic lysosomal storage disease.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May